Clinical Trial Update: ECMOsorb Trial - Impact of a VA-ECMO in Combination With CytoSorb in Critically Ill Patients With Cardiogenic Shock [NA]

View source ↗

Summary

The ECMOsorb trial evaluating VA-ECMO combined with CytoSorb in critically ill patients with cardiogenic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Snippet

Sponsor: Christian Schulze | Conditions: Cardiogenic Shock | NA | Status: COMPLETED